Publication: The relationship between members of the canonical NF-kB pathway, tumour microenvironment and cancer specific survival in colorectal cancer patients
Authors
Quinn, Jean A ; Bennett, Lindsay ; Patel, Meera ; Frixou, Mikaela ; Park, James H. ; Roseweir, Antonia ; Horgan, Paul G ; McMillan, Donald C ; Edwards, Joanne
item.page.secondaryauthor
item.page.director
Publisher
Universidad de Murcia, Departamento de Biologia Celular e Histiologia
publication.page.editor
publication.page.department
DOI
https://doi.org/10.14670/HH-18-168
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Background. The aim of this study was to
investigate the role of the upstream kinase TAK1 and
the canonical NF-κB pathway in colorectal cancer
(CRC). Immunohistochemistry was used to assess the
expression of TAK1/pTAK1 and canonical NF-κB
pathway members in a tissue microarray of 242
patients. The relationship between expression, the
tumour microenvironment and cancer-specific survival
were examined. Results. All the investigated members
of the pathway were expressed in CRC tissue. In
addition, cytoplasmic pTAK1 was associated with the
tumour microenvironment (P=0.045) and cancer-
specific survival (CSS) (P=0.032). When cytoplasmic
pTAK1 was stratified by BRAF status, cytoplasmic
pTAK1 expression association with CSS was
strengthened (P=0.014). Cytoplasmic IKKβ was
significantly associated with the inflammatory cell
infiltrate (P=0.015) as graded by Klintrup Makinen
grade, systemic inflammation as assessed by neutrophil-
lymphocyte ratio (P=0.03) and CSS (P=0.046). On
multivariate analysis cytoplasmic IKKβ was
independently associated with CSS (HR 1.75,95%CI
1.05-2.91, P=0.033). Conclusion. Cytoplasmic pTAK1
was significantly associated with CSS and this was
enhanced in patients with tumours that expressed wild
type BRAF. High expression of cytoplasmic IKKβ was
significantly associated with decreased CSS and with
markers of the tumour microenvironment. These results
support the hypothesis that NF-κB pathway members
are poor prognostic markers in patients with CRC, but
this requires to be validated in a large independent
cohort
publication.page.subject
Citation
Histology and Histopathology Vol. 35, nº6 (2020)
item.page.embargo
Ir a Estadísticas
Este ítem está sujeto a una licencia Creative Commons. http://creativecommons.org/licenses/by-nc-nd/4.0/